Detection of nonsterol isoprenoids by HPLC-MS/MS

Analytical Biochemistry

Volumn 383, Issue 1, 2008, Pages 18-24

  Henneman, Linda ^a   van Cruchten, Arno G ^a   Denis, Simone W ^a   Amolins, Michael W ^b   Placzek, Andrew T ^b   Gibbs, Richard A ^b   Kulik, Willem ^a   Waterham, Hans R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Farnesyl pyrophosphate; Geranylgeranyl pyrophosphate; Isoprenoid biosynthesis; Mass spectrometry; Mevalonate kinase deficiency

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; CELLS; CYTOLOGY; MASS SPECTROMETRY; REACTION INTERMEDIATES; SILICA;

FARNESYL PYROPHOSPHATES; GERANYLGERANYL PYROPHOSPHATE; ISOPRENOID BIOSYNTHESIS; MEVALONATE KINASE; MULTIPLE-REACTION MONITORING MODES; POTENTIAL INHIBITORS; SIMULTANEOUS DETECTION; TANDEM MASS SPECTROMETRY;

LIPIDS;

FLUORESCENT DYE; GERANYLTRANSFERASE; ISOPENTENYL DIPHOSPHATE; ISOPRENOID; MEVALONIC ACID; PAMIDRONIC ACID; PHOSPHOMEVALONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL FREE SYSTEM; CELL STRAIN HEPG2; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MASS SPECTROMETRY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TERPENES;

EID: 53249124644     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.08.023     Document Type: Article

References (29)

1. Casey P.J., and Seabra M.C. Protein prenyltransferases. J. Biol. Chem. 271 (1996) 5289-5292
2. McTaggart S.J. Isoprenylated proteins. Cell Mol. Life Sci. 63 (2006) 255-267
3. Jemal M., Schuster A., and Whigan D.B. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. Rapid Commun. Mass Spectrom. 17 (2003) 1723-1734
4. Saini G.S., Wani T.A., Gautam A., Varshney B., Ahmed T., Rajan K.S., Pillai K.K., and Paliwal J.K. Validation of the LC-MS/MS method for the quantification of mevalonic acid in human plasma and determination of the matrix effect. J. Lipid Res. 47 (2006) 2340-2345
5. Scoppola A., Maher V.M., Thompson G.R., Rendell N.B., and Taylor G.W. Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J. Lipid Res. 32 (1991) 1057-1060
6. Siavoshian S., Simoneau C., Maugeais P., Marks L., Rodary L., Gardette J., and Krempf M. Measurement of mevalonic acid in human urine by bench top gas chromatography-mass spectrometry. Clin. Chim. Acta 243 (1995) 129-136
7. Woollen B.H., Holme P.C., Northway W.J., and Martin P.D. Determination of mevalonic acid in human urine as mevalonic acid lactone by gas chromatography-mass spectrometry. J. Chromatogr. B 760 (2001) 179-184
8. Saisho Y., Kuroda T., and Umeda T. A sensitive and selective method for the determination of mevalonic acid in dog plasma by gas chromatography/negative ion chemical ionization-mass spectrometry. J. Pharm. Biomed. Anal. 15 (1997) 1223-1230
9. Fisher A.J., Rosenstiel T.N., Shirk M.C., and Fall R. Nonradioactive assay for cellular dimethylallyl diphosphate. Anal. Biochem. 292 (2001) 272-279
10. Saisho Y., Morimoto A., and Umeda T. Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal. Biochem. 252 (1997) 89-95
11. Song L. Detection of farnesyl diphosphate accumulation in yeast ERG9 mutants. Anal. Biochem. 317 (2003) 180-185
12. Keller R.K. Squalene synthase inhibition alters metabolism of nonsterols in rat liver. Biochim. Biophys. Acta 1303 (1996) 169-179
13. Tong H., Holstein S.A., and Hohl R.J. Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells. Anal. Biochem. 336 (2005) 51-59
14. Bruenger E., and Rilling H.C. Determination of isopentenyl diphosphate and farnesyl diphosphate in tissue samples with a comment on secondary regulation of polyisoprenoid biosynthesis. Anal. Biochem. 173 (1988) 321-327
15. McCaskill D., and Croteau R. Procedures for the isolation and quantification of the intermediates of the mevalonic acid pathway. Anal. Biochem. 215 (1993) 142-149
16. Zhang D., and Poulter C.D. Analysis and purification of phosphorylated isoprenoids by reversed-phase HPLC. Anal. Biochem. 213 (1993) 356-361
17. Hogenboom S., Romeijn G.J., Houten S.M., Baes M., Wanders R.J., and Waterham H.R. Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis. J. Lipid Res. 43 (2002) 90-98
18. Hoffmann G.F., Brendel S.U., Scharfschwerdt S.R., Shin Y.S., Speidel I.M., and Gibson K.M. Mevalonate kinase assay using DEAE-cellulose column chromatography for first-trimester prenatal diagnosis and complementation analysis in mevalonic aciduria. J. Inherit. Metab. Dis. 15 (1992) 738-746
19. Wanders R.J.A., and Romeijn G.J. Differential deficiency of mevalonate kinase and phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis: evidence for a major role of peroxisomes in cholesterol biosynthesis. Biochem. Biophys. Res. Commun. 247 (1998) 663-667
20. Gibbs R.A., Krishnan U., Dolence J.M., and Poulter C.D. A stereoselective palladium/copper-catalyzed route to isoprenoids: synthesis and biological evaluation of 13-methylidenefarnesyl diphosphate. J. Org. Chem. 60 (1995) 7821-7829
21. Zahn T.J., Eilers M., Guo Z., Ksebati M.B., Simon M., Scholten J.D., Smith S.O., and Gibbs R.A. Evaluation of isoprenoid conformation in solution and in the active site of protein-farnesyl transferase using carbon-13 labeling in conjunction with solution- and solid-state NMR. J. Am. Chem. Soc. 122 (2000) 7153-7164
22. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
23. Gibson K.M., Hoffmann G., Schwall A., Broock R.L., Aramaki S., Sweetman L., Nyhan W.L., Brandt I.K., Wappner R.S., and Lehnert W. 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. J. Lipid Res. 31 (1990) 515-521
24. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
25. Seker T., Moller K., and Nielsen J. Analysis of acyl CoA ester intermediates of the mevalonate pathway in Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 67 (2005) 119-124
26. Houten S.M., Frenkel J., and Waterham H.R. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol. Life Sci. 60 (2003) 1118-1134
27. Basso A.D., Kirschmeier P., and Bishop W.R. Lipid posttranslational modifications: farnesyl transferase inhibitors. J. Lipid Res. 47 (2006) 15-31
28. Caraglia M., Budillon A., Tagliaferri P., Marra M., Abbruzzese A., and Caponigro F. Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications. Curr. Drug Targets 6 (2005) 301-323
29. Charlton-Menys V., and Durrington P.N. Squalene synthase inhibitors: clinical pharmacology and cholesterol-lowering potential. Drugs 67 (2007) 11-16